MediPoint: Enteral Stents - APAC Forecast and Market Analysis
Enteral stents market is a growing medical market throughout all geographies. The market is driven primarily by rising cancer rates, specifically esophageal, stomach, pancreatic, and colorectal cancers, and by an increased awareness of stenting as a palliative treatment. Overall, the fully covered enteral stents account for the largest market share, followed by partially covered enteral stents, and both of these markets are growing throughout the forecast period. The non-covered enteral stents market, however, is a declining market, as they are more likely to result in tumor ingrowth and result in further complications. This trend is seen throughout the global enteral stents market.
Enteral stents are a palliative treatment option for constrictions caused primarily by various cancers. The primary cancers which cause constrictions requiring the use of enteral stents are esophageal cancer, gastric cancer, pancreatic cancer, and colorectal cancer. There are three primary enteral stents; the covered enteral stent, the partially covered enteral stents, and the non-covered enteral stent.
The APAC market for enteral stents, which encompasses seven countries and includes esophageal stents, gastrointestinal stents, and colonic stents, was valued at approximately $67.3M in 2016. The market is expected to grow at a CAGR of 3.5%, to reach a valuation of $85.5M in 2023.
The key drivers of this market during the forecast period are -
Increased cancer rates driven by an increased intake of toxins such as tobacco and alcohol.
Increase in diseases such as diabetes, as well as obesity.
Development of stenting technology.
There are three key players in the international enteral stents market. Boston Scientific is the leading company in the enteral stents market thanks to an extensive product line and a presence in all segments of the enteral stents market. Its presence was further strengthenedby the acquisition of EndoChoice, a former smaller player in the enteral stents market. The other two key players in the enteral stents market are Cook Medical and Taewoong Medical. Cook Medical has established a strong presence despite a small product line, while Taewoong Medical has a more extensive product portfolio.
The report MediPoint: Enteral Stents - APAC Forecast and Market Analysis examines the enteral stents market in seven major Asia-Pacific (APAC) markets: Australia, China, India, Japan, New Zealand, South Korea, and Taiwan. This report provides insight into the adoption trends, market dynamics, competitive landscape, marketed products, current players, as well as market outlooks in the APAC market.
Companies mentioned in this report: Boston Scientific, EndoChoice, Taewoong Medical, Cook Medical. Merit Medical, Leufen Medical, ELLA-CS, M.I.Tech.